Login / Signup
Improving Our Aim: Targeting Therapy with Roflumilast in Patients with Severe and Very Severe Chronic Obstructive Pulmonary Disease.
Bartolome R Celli
Published in:
American journal of respiratory and critical care medicine (2019)
Keyphrases
</>
chronic obstructive pulmonary disease
early onset
lung function
mesenchymal stem cells
bone marrow